PMC:7402624 / 49817-50041
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T429 | 144-154 | Body_part | denotes | eosinophil | http://purl.org/sig/ont/fma/fma62861 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1647 | 203-213 | Chemical | denotes | Remdesivir | MESH:C000606551 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T91403 | 162-167 | Chemical | denotes | NSAID | http://purl.obolibrary.org/obo/CHEBI_35475 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T288 | 0-224 | Sentence | denotes | In contrast, Component 2 lacked positive correlation to many of these clinical features of disease and rather was negatively correlated only to eosinophil count, NSAID use, and subsequent treatment with Remdesivir (Fig. 6I). |